|
SNS Diagnostics Limited Outstanding Shares: |
1350000 |
|
Face Value of SNS Diagnostics Share: |
Rs. 10 Per Equity Share |
|
ISIN of SNS Diagnostics Limited Share: |
INE362S01018 |
|
Lot Size of SNS Diagnostics Share: |
100 |
|
SNS Diagnostics Share Price: |
Best In Industry |
|
PAN Number of SNS Diagnostics : |
AAACS0339M |
|
GST Number of SNS Diagnostics : |
-- |
|
SNS Diagnostics Limited CIN Number |
L74899DL1983PLC016371 |
|
SNS Diagnostics Limited Registration Date |
19-Aug-83 |
|
Category / Sub-Category of SNS Diagnostics Limited |
Public Companies having a share capital |
|
SNS Diagnostics Limited Registered Office Address |
ROOM NO. 106, FIRST FLOOR, 2162/T-10 A, GURU ARJUN NAGAR, MAIN PATEL ROAD NEW DELHI West Delhi DL 110008 IN. |
|
SNS Diagnostics Limited Registrar & Transfer Agent Address & Contact Details |
302, Kushal Bazar, 32-33, Nehru Place, New Delhi - 110019 |
Director | Post |
Mr. Dharmendra Gupta | Managing Director |
Ms. Mehak Arora | Woman Independent Director |
Mr. Ram Sunder | Additional independent Director |
FAQs on SNS Diagnostics Ltd
Q: What is the face value of SNS Diagnostics Ltd shares?
Answer: The face value of SNS Diagnostics Ltd is ₹10 per equity share.
Q: What is the minimum lot size for buying SNS Diagnostics shares through WWIPL?
Answer: The minimum lot size for SNS Diagnostics shares is 100 equity shares.
Q: How can I buy SNS Diagnostics unlisted shares through WWIPL?
Answer: Investors can complete the KYC process, confirm the transaction details with WWIPL, transfer funds, and receive shares directly in their Demat account.
Q: Why should I buy SNS Diagnostics shares through WWIPL?
Answer: WWIPL offers transparent pricing, secure transactions, seamless Demat transfers, and dedicated support throughout the investment process.
Q: Is investing in SNS Diagnostics Ltd a good idea?
Answer: Investors often evaluate SNS Diagnostics based on its presence in the diagnostics and healthcare services industry, financial performance, operational scale, and long-term growth potential.
Q: Why do investors buy SNS Diagnostics shares before a potential IPO?
Answer: Investors seek early exposure to a growing diagnostics company before listing, aiming to participate in future value creation and potential liquidity events.
Q: What business does SNS Diagnostics Ltd operate in?
Answer: SNS Diagnostics operates in the diagnostic and pathology services industry, providing laboratory testing, health check-up packages, and diagnostic solutions to patients, healthcare providers, and corporate clients.
Q: Who founded SNS Diagnostics Ltd?
Answer: SNS Diagnostics was established to provide quality diagnostic and pathology services, with a focus on delivering reliable and accurate healthcare testing solutions.
Q: What makes SNS Diagnostics different from other unlisted healthcare companies?
Answer: SNS Diagnostics combines diagnostic laboratory services with preventive healthcare solutions, supported by an expanding network and increasing demand for quality diagnostics.
Q: What are the key growth drivers for SNS Diagnostics Ltd?
Answer: Rising healthcare awareness, increasing preventive health check-ups, expansion of diagnostic centers, technological advancements, and growing demand for pathology services are key growth drivers.
Q: What factors affect the valuation of SNS Diagnostics shares?
Answer: Revenue growth, profitability, laboratory network expansion, testing volumes, operational efficiency, market demand for unlisted shares, and future listing prospects are important valuation drivers.
Q: Are SNS Diagnostics shares available in Demat form?
Answer: Yes. Shares purchased through WWIPL are transferred directly to the investor's Demat account.
Q: Can I sell my SNS Diagnostics shares through WWIPL?
Answer: Yes. WWIPL facilitates both buying and selling of unlisted shares, subject to market demand and share availability.
Q: What documents are required to buy SNS Diagnostics shares through WWIPL?
Answer: Investors generally need PAN, Aadhaar, Client Master Report (CMR), and bank account details to complete the transaction.
Q: What are the risks of investing in SNS Diagnostics shares?
Answer: Investors should consider competition in the diagnostics industry, regulatory changes, execution risks, profitability fluctuations, and liquidity constraints associated with unlisted shares.
Q: How does WWIPL help investors track SNS Diagnostics investments?
Answer: WWIPL provides company updates, transaction assistance, market information, and investment insights to help investors stay informed.
Q: How long does it take for SNS Diagnostics shares purchased through WWIPL to be credited to a Demat account?
Answer: Shares are generally transferred to the investor's Demat account after successful completion and verification of the transaction.
Q: What should investors evaluate before investing in SNS Diagnostics Ltd?
Answer: Investors should assess the company's financial performance, laboratory network, profitability, competitive position, valuation, and long-term growth prospects.
Q: Can SNS Diagnostics benefit from India's growing diagnostics and healthcare industry?
Answer: Yes. Increasing healthcare awareness, rising demand for preventive diagnostics, expanding health insurance coverage, and growth in organized diagnostic services may create significant long-term growth opportunities for the company.
